Pricing Log in Create free account

BioXcel Therapeutics, Inc. (BTAIQ) vs Lucy Scientific Discovery Inc. (LSDIF)

BioXcel Therapeutics, Inc. and Lucy Scientific Discovery Inc. are both Drug Manufacturers Specialty & Generic companies. BioXcel Therapeutics, Inc. is the larger, with a market value of $2.3M against $900.0K — 2.6× the size. Lucy Scientific Discovery Inc. has the higher net margin (0.00% vs −9,549.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Lucy Scientific Discovery Inc. leads on 8 and BioXcel Therapeutics, Inc. on 4.

Valuation

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.23 n/m 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 228.32 n/m 2.73
Earnings yield (12,633.33%) 0.00% (4.38%)
Free cash flow yield (5,602.20%) 0.00% 0.00%

Profitability

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
Gross margin 53.10% 0.00% 53.94%
Operating margin (6,054.72%) 0.00% 0.00%
Net margin (9,549.87%) 0.00% 0.00%
Free cash flow margin (6,860.38%) 0.00% 0.00%
Return on equity 63.52% 337.20% (0.40%)
Return on assets (259.62%) (249.36%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (14.52%) — 10.01%
EPS growth (last fiscal year) 75.63% (4.46%) 49.06%
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.00 0.05
Current ratio 0.21 0.38 2.31
Net debt to EBITDA (1.61) 0.29 0.97

Dividend

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BTAIQ LSDIF Drug Manufacturers Specialty & Generic median
Market cap 2.31m 900.00k 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack